Further analysis revealed that ASAP2 also exhibited higher expression levels in other types of malignancies, such as cholangiocarcinoma, head and neck squamous cell carcinoma, and lung squamous cell carcinoma (Additional file 1: Fig. S1D). Here, ASAP2 is linked to cholangiocarcinoma.